Privia Health (PRVA) shares fell 13% in Thursday trading after the company reported Q2 adjusted earnings that missed Wall Street expectations.
The company reported Q2 non-GAAP earnings of $0.19 per diluted share, up from $0.17 a year earlier.
Analysts polled by FactSet expected $0.24.
Revenue for the quarter ended June 30 was $632.6 million, compared with $521.2 million a year earlier.
Analysts polled by FactSet expected $597.3 million.
For 2026, the company said it expects GAAP revenue at the high end of its previously issued guidance range of $2.35 billion to $2.45 billion. Analysts surveyed by FactSet expect $2.42 billion.
Price: $20.55, Change: $-3.41, Percent Change: -14.23%